An international team, writing in the British Journal of Cancer, examined 40 separate studies looking at the potential link between breast cancer and diabetes. Post-menopausal women who have Type 2 diabetes appear to have a 27% greater risk of developing breast cancer, experts say.
The authors have also suggested that a high body mass index (BMI), which is often associated with diabetes, may be an underlying contributing factor.
Full article: http://www.bbc.co.uk/news/health-19585931
*******************
Obesity was linked to shorter time to recurrence, disease-free survival and overall survival. The exception was treatment with endocrine therapy, in which obesity was associated with a protective effect.
Full article: http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=28589
********************
"We found that BMI was related to both relapse-free survival and overall survival; for example, the 10-year relapse-free survival of a patient who was overweight was 70 percent; compared with 65 percent for one who was obese," she noted.
Our study mandated that each patient received a chemotherapy dose adjusted to her weight, so these results suggest that treatment factors are not responsible for the differences in recurrence rates seen in heavier women," Ligibel said in a conference news release.
Full article: http://www.medicinenet.com/script/main/art.asp?articlekey=156293
The authors have also suggested that a high body mass index (BMI), which is often associated with diabetes, may be an underlying contributing factor.
Full article: http://www.bbc.co.uk/news/health-19585931
*******************
Obesity was linked to shorter time to recurrence, disease-free survival and overall survival. The exception was treatment with endocrine therapy, in which obesity was associated with a protective effect.
Full article: http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=28589
********************
"We found that BMI was related to both relapse-free survival and overall survival; for example, the 10-year relapse-free survival of a patient who was overweight was 70 percent; compared with 65 percent for one who was obese," she noted.
Our study mandated that each patient received a chemotherapy dose adjusted to her weight, so these results suggest that treatment factors are not responsible for the differences in recurrence rates seen in heavier women," Ligibel said in a conference news release.
Full article: http://www.medicinenet.com/script/main/art.asp?articlekey=156293